Investigators from Shanghai, China, report responses above 90% by using levantinib and tislelizumab to treat patients with a ...
Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, ...
Amgen will continue to advance half of the combo, PRMT5 inhibitor AMG 193, for which it is running a mid-stage trial in ...
Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...
No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...
The Rice lab of bioengineer Gang Bao and collaborators at Baylor College of Medicine have developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the ...
Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...
Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...
Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...
A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...
A novel 3D bioprinted gastric cancer model using patient-derived tissues predicts drug responses, enhancing personalized ...
The new study adds to growing evidence that measuring activated proteins is key to cancer therapy selection.Golden, CO, Feb. 10, 2025 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback